Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Johann MOLS"'
Autor:
Gary Fahle, Robin K. Avery, Debra Birnkrant, Jeffrey C. Murray, Yoshihiko Murata, Mary Singer, Randi Y. Leavitt, Hans H. Hirsch, Lynn Fallon, Francisco Martinez-Murillo, John E. McKinnon, Gavin Cloherty, Randall Lanier, Rekha Abichandani, Philip R. Krause, Sally Mossman, M Michelle Berrey, Wael Saber, Ali Alghamdi, John A. D. Leake, Raymund R. Razonable, Takashi E. Komatsu, Emily A. Blumberg, Mahmood Tazari, Kurt Gunter, Thomas Mertens, Jens D Lundgren, Yoichiro Natori, Sunwen Chou, Kevin Modarress, Jay Erdman, Li Li, Terry Bowlin, Peter W. Hunt, William Cruikshank, Anna Wijatyk, Frank Kuhr, Garrett Nichols, Aimee Hodowanec, Marcie L. Riches, Shahid Husain, Karl S. Peggs, Jules O'Rear, Johann Mols, Filip Josephson, Christopher Lademacher, Paul Baum, Bernhardt Zeiher, Paul D. Griffiths, Susan Barnett, Mark N. Prichard, Michael Boeckh, Roy F. Chemaly, Megan McCutcheon, Thomas Stamminger, Fausto Baldanti, Chalom Sayada, Veronica Miller, Andreas Pikis, Atul Humar, Dimitri Gonzalez, Barbara D. Alexander, Jennifer Brooks, Jeff Roberts, Camille N. Kotton, Hermann Einsele, Tadd Lazarus, David Boutolleau, Deepali Kumar, Sandra Nusinoff Lehrman, Ani Orchanian-Cheff, Howard Mayer, Heather Gillis, Dong Yu, David Murawski, Per Ljungman, Paula Isabelle Lodding, Lesia K. Dropulic
Publikováno v:
Clinical Infectious Diseases. 66:617-631
Symptomatic cytomegalovirus (CMV) disease has been the standard endpoint for clinical trials in organ transplant recipients. Viral load may be a more relevant endpoint due to low frequency of disease. We performed a meta-analysis and systematic revie
Publikováno v:
Human Vaccines & Immunotherapeutics
We present an age-structured dynamic transmission model for cytomegalovirus (CMV) in the United States, based on natural history and available data, primarily aiming to combine the available qualitative and quantitative knowledge toward more complex
Autor:
Gerald Voss, Nicolas Dumey, Johann Mols, Olga Rovira, Clarisse Lorin, Frédérick Le Goff, Patricia Bourguignon, Pascal Mettens, Frédéric Tangy, Jérémy Silvano, Lawrence Segal, Marguerite Koutsoukos, Danielle Morelle
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology
As a new human immunodeficiency virus type 1 (HIV-1) vaccine approach, the live-attenuated measles virus (MV) Schwarz vaccine strain was genetically engineered to express the F4 antigen (MV1-F4). F4 is a fusion protein comprising HIV-1 antigens p17 a
Autor:
Anco Molijn, Wim Quint, Christine Van Hoof, Karin Hardt, Johann Mols, Linda Struijk, John Doorbar, Frank Struyf, Brigitte Desiree Alberte Colau, Miekel M. van de Sandt, D. G. Jenkins
Publikováno v:
The Journal of Pathology. 227:62-71
In 20-40% of cervical intra-epithelial neoplasia (CIN) and in 4-8% of cervical carcinoma tissue specimens, multiple HPV genotypes have been detected. Whole tissue section (WTS) PCR does not determine how the individual types relate causally to comple
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1779:712-719
The control of mRNA stability is a complex biological process that involves numerous factors, including microRNA (miRNA) and short interfering RNA (siRNA). Here, we show that short interfering RNA (siRNA) and microRNA share some similarities in their
Autor:
Young Jun Kang, Qing Jing, Xin Du, Asit K. Pattnaik, Zhengfan Jiang, Liguo New, Johann Mols, Ryan Cook, Jianming Chen, Jiahuai Han, Subash C. Das, Motoyuki Otsuka, Bruce Beutler, Philippe Georgel
Publikováno v:
Immunity. 27:123-134
Summary Dicer is essential for plant, Caenorhabditis elegans , and Drosophila antiviral responses because of its role in generating small interfering RNA (siRNA) from viral genomes. We show that because of impaired miRNA production, mice with a varia
Autor:
Zhengfan Jiang, Philippe Georgel, Siamak Bahram, Stefan Kunz, Edith M. Janssen, Kasper Hoebe, Michael B. A. Oldstone, Bruce Beutler, Johann Mols
Publikováno v:
Virology. 362:304-313
We have previously shown that mutations of CD14 or TLR4 impair type I interferon (IFN) production and macrophage survival during infection with vesicular stomatitis virus (VSV). We now report that VSV glycoprotein G (gpG) is essential for the inducti
Publikováno v:
Journal of Virological Methods. 188:145-147
This was a multicenter, non-therapeutic study to determine the optimal type of lesion sample for quantitative PCR detection of varicella zoster virus (VZV) DNA in herpes zoster patients. Up to three crusts, three crust swabs, three vesicle swabs, and
Publikováno v:
Biotechnology Letters. 26:1043-1046
CHO-320 cells, cultivated in suspension in a protein-free medium supplemented with rice protein hydrolysates (peptones), secrete recombinant interferon-gamma (IFN-gamma) that undergo will or will not proteolysis, depending on the origin of the pepton
Autor:
Roman Chlibek, Johann Mols, Edouard Ledent, Thomas C. Heineman, Maria Luisa Rodriguez de la Pinta, Harry Collins, José M Bayas
Publikováno v:
The Journal of infectious diseases. 208(12)
Background An adjuvanted varicella-zoster virus glycoprotein E (gE) subunit vaccine candidate for herpes zoster is in development. In this trial we compared the safety, reactogenicity, and immunogenicity of the vaccine antigen combined with different